Upgrades Archives - Page 152 of 188

1 minute read

Why This Gilead Analyst Believes The Stock Is Highly Undervalued

October 4, 12:03 PM

While there is increased visibility for Gilead Sciences, Inc’s (NASDAQ: GILD) HIV franchise, its emerging oncology franchise is not well reflected in its valuation, according to JPMorgan.

GILD

1 minute read

Citigroup Upgrades Bank of New York Mellon to Buy

By Benzinga Newsdesk

October 4, 9:26 AM

Citigroup analyst Keith Horowitz upgrades Bank of New York Mellon (NYSE:BK) from Neutral to Buy.

1 minute read

Credit Suisse Upgrades CommScope Hldg Co to Outperform, Raises Price Target to $17

By Benzinga Newsdesk

October 4, 6:17 AM

Credit Suisse analyst Sami Badri upgrades CommScope Hldg Co (NASDAQ:COMM) from Neutral to Outperform and raises the price target from $11 to $17.

COMM

1 minute read

JP Morgan Upgrades Gilead Sciences to Overweight, Raises Price Target to $80

By Benzinga Newsdesk

October 4, 5:51 AM

JP Morgan analyst Chris Schott upgrades Gilead Sciences (NASDAQ:GILD) from Neutral to Overweight and raises the price target from $72 to $80.

GILD

1 minute read

Morgan Stanley Upgrades Box to Overweight, Raises Price Target to $34

By Benzinga Newsdesk

October 3, 6:14 AM

Morgan Stanley analyst Josh Baer upgrades Box (NYSE:BOX) from Equal-Weight to Overweight and raises the price target from $32 to $34.

BOX

1 minute read

Truist Securities Upgrades Southwestern Energy to Buy, Raises Price Target to $11

By Benzinga Newsdesk

October 3, 6:07 AM

Truist Securities analyst Neal Dingmann upgrades Southwestern Energy (NYSE:SWN) from Hold to Buy and raises the price target from $7 to $11.

SWN

2 minute read

Is 2023 The ‘Trickle-Down Year’ For NOV? Why This Wall Street Analyst Is Bullish

By Robert Kuczmarski

September 30, 1:21 PM

Bank Of America analyst Chase Mulvehill upgraded NOV (NYSE: NOV) with a price target of $19. Key Takeaways: "Trickle-down on the move; upgrade to Buy," Mulvehill said in a note.

CHX